IVRI Cell Signalling JRF Walk IN 2018 December ~ helpBIOTECH

12 December 2018

IVRI Cell Signalling JRF Walk IN 2018 December


ICAR-INDIAN VETERINARY RESEARCH INSTITUTE 
IZATNAGAR, BAREILLY (U.P.)– 243 122 

A walk in interview is scheduled at the Division of Pharmacology and Toxicology of the Institute on 21-12-2018 at 10:30 AM for engagement of one Junior Research Fellow in DST funded project entitled ‘Pharmacodynamic modulation of cardiac angiotensin and adrenergic signaling in arsenic-exposed rats’. The engagement is purely temporary on contractual basis, co-terminus with the project. 

A. Qualifications: Essential: M.Pharm or M Tech/M.Sc. in life sciences (NET qualification is essential for M.Sc Candidates). or M.V.Sc. in Veterinary Pharmacology/Veterinary Pharmacology and Toxicology/ allied disciplines of Veterinary and Animal Sciences/ Graduate degree in professional courses with NET qualification. 

Desirable: 

 Working knowledge in molecular biology techniques such as q-PCR, Western blot, ELISA and Isolated organ experiments etc. 
 Handling and management of laboratory rats. 
 Knowledge in computer application and data management. 

B. Emoluments: Rs.25,000 per month plus HRA admissible as per DST norms. 

C. Age limit: 35 years (relaxation admissible for women candidates as per Govt. of India norms). 

D. Duration/Period of the project: up to July, 2021 

E. Date, Time and Place of Interview: 21-12-2018 at 10:30 AM Committee room of Pharmacology and Toxicology Division, IVRI, Izatnagar. 

F. Name of the PI/Contact Person: Dr. Kesavan, M, Scientist E-mail: drkesuvet@gmail.com 

G. Terms and conditions: Candidates fulfilling the qualification may appear directly in “Walk-in-Interview”. Candidates attending interview are required to bring their recent bio-data, original and one photocopy of self attested marks sheets, degree certificates and two passport size photographs. The applicants may also send their bio-data in advance by e-mail to drkesuvet@gmail.com. No TA/DA will be provided for attending the interview. 

0 Comments:

Post a Comment

Enter your email address:

Delivered by FeedBurner